Announced
Completed
Financials
Sources
Tags
Biotechnology
Completed
Cross Border
biology-gated transistors
Majority
Private
Acquisition
Friendly
Single Bidder
United States
Synopsis
Paragraf, the only company in the world to mass produce graphene electronics, completed the acquisition of Cardea Bio, a producer of graphene-based biocompatible chips. Financial terms were not disclosed. “The world-leading IP and expertise in graphene-electronic-based molecular detection using CRISPR and other bioassay methods from Cardea Bio, combined with Paragraf’s ground-breaking developments in scalable graphene production processes will deliver a strong pipeline of biosensing products aimed at solving major global challenges,” Simon Thomas, Paragraf CEO and Co-founder.
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.